Dov Gertz
Founder & CEO · Converge Bio · Tel Aviv-Yafo, Tel Aviv, Israel
Biotechnology Research · Series A · Founded 2024
Latest raise
$25M
Date raised
January 13, 2026
Round
Series A
About Dov Gertz
Converge Bio is accelerating drug development through GenAI-powered innovations in discovery, molecule design and manufacturing to create the therapies of tomorrow, today.
- Who is Dov Gertz?
- Dov Gertz is listed as Founder & CEO of Converge Bio, a biotechnology research company founded in 2024 based in Tel Aviv-Yafo, Tel Aviv, Israel.
- How much did Converge Bio raise?
- Converge Bio raised $25M in a Series A round on January 13, 2026 (293 days ago). Backed by Bessemer Venture Partners.
Get newly funded founders every week
A free weekly list of startups that just raised.